Instil Bio: Second-Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF Success #Instil #Bio #SecondHalf #AXN2510 #Data…
Tag: Bio
H.C. Wainwright lifts Instil Bio stock target to $125
H.C. Wainwright lifts Instil Bio stock target to $125#H.C #Wainwright #lifts #Instil #Bio #stock #target
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation…
Tourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 Inhibition
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…
Protagenic Therapeutics Skyrockets on Merger with Phytanix Bio: A Biotech Powerhouse in the Making?
Holy cow, folks, the market’s on fire today, and Protagenic Therapeutics (Nasdaq: PTIX) is leading the…
Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call Transcript
Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call Transcript #Gossamer #Bio #GOSS #Earnings #Conference #Call…
Fieldstone Bio is building microbes that can sense everything from TNT to arsenic
The world is awash in data about, well, the world — thanks to satellites and environmental…
Bluebird Bio Stock Skyrockets on Revamped Buyout Offer
Hold onto your hats, traders! If you’re keeping an eye on the market today, you’ve likely…
INmune Bio, Inc. (INMB) Q1 2025 Earnings Call Transcript
INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company…
Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript #BioRad #Laboratories #BIO #Earnings #Call #Transcript
Nuvation Bio CEO David Hung purchases $820,220 in company stock
Nuvation Bio CEO David Hung purchases $820,220 in company stock#Nuvation #Bio #CEO #David #Hung #purchases #company…
Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data
Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data #Tourmaline #Bio #Wait #Upcoming #Phase…
Korro Bio: Promising Early Stage RNA Editing Company (NASDAQ:KRRO)
This article was written by Follow Avisol Capital Partners is made up of a team of…
TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript
TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript #TELA #Bio #TELA #Earnings #Call #Transcript
Generation Bio director Quinn Anthony buys $203k in shares By Investing.com
CAMBRIDGE, Mass.—Quinn Anthony G., a director at Generation Bio Co. (NASDAQ:GBIO), recently made significant purchases of…
INmune Bio: XPro Cognitive Readout In Sight, But Mind The Financial Dangers
INmune Bio: XPro Cognitive Readout In Sight, But Mind The Financial Dangers #INmune #Bio #XPro #Cognitive…
Tevogen Bio Holdings: Excessive Insider Ownership And Poised For A Seasonal Rebound
This article was written by Follow Full name for licenses is Anthony Joseph (“A.J.”) Cataldo II,…